We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sealed Air (SEE) Tops Earnings Estimates in Q1, Revenues Lag
Read MoreHide Full Article
Sealed Air Corporation (SEE - Free Report) , a global leader in food safety and security, facility hygiene and product protection, reported first-quarter 2017 results, wherein adjusted earnings of 51 cents surpassed the Zacks Consensus Estimate of 50 cents.
Revenue: Sealed Air posted revenues of $1,131 million, missing the Zacks Consensus Estimate of $1,136 million.
Guidance: For 2018, Sealed Air guides net sales of approximately $4.75 to $4.80 billion, a constant dollar growth rate of approximately 4.5%. Adjusted EBITDA from continuing operations is expected to be in the range of $890 million to $910 million. Adjusted earnings per share is projected at $2.45-$2.55, up from the previous guidance of $2.35-$2.45.
Earnings Estimates Revision: The Zacks Consensus Estimate for first quarter has been stable over the past 30 days. In the trailing four quarters, excluding quarter under review, the company’s earnings have missed the Zacks Consensus Estimate by an average of nearly 1.89%.
Market Reaction: Sealed Air’s shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on Sealed Air earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Sealed Air (SEE) Tops Earnings Estimates in Q1, Revenues Lag
Sealed Air Corporation price-eps-surprise | Sealed Air Corporation Quote
Zacks Rank: Currently, Sealed Air carries a Zacks Rank #2 (Buy) which is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Market Reaction: Sealed Air’s shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on Sealed Air earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>